ORMP - Oramed Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart Insider Trading

ORMP is currently covered by 3 analysts with an average price target of $12.16. This is a potential upside of $9.34 (331.21%) from yesterday's end of day stock price of $2.82.

Oramed Pharmaceuticals's activity chart (see below) currently has 15 price targets and 18 ratings on display. The stock rating distribution of ORMP is 75% BUY and 25% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 55% with an average time for these price targets to be met of 125.75 days.

Highest price target for ORMP is $2, Lowest price target is $2, average price target is $12.16.

Most recent stock forecast was given by EDWARD NASH from CANACCORD on 17-May-2023. First documented stock forecast 04-Dec-2013.

Best performing analysts who are covering ORMP - Oramed Pharmaceuticals:

Raghuram Selvaraju Edward Nash Nathan Weinstein Jim Molloy

Currently out of the existing stock ratings of ORMP, 3 are a BUY (75%), 1 are a HOLD (25%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

2

$-0.82 (-29.08%)

3

10 months 11 days ago

3/5 (60%)

$-1.63 (-44.90%)

157

Buy

32

1 years 2 months 11 days ago

3/5 (60%)

$18.28 (133.24%)

278

Buy

35

1 years 10 months 12 days ago

1/2 (50%)

$9.92 (39.55%)

62

Buy

40

$37.78 (1701.80%)

11

2 years 4 months 19 days ago

1/2 (50%)

$10.78 (36.89%)

6

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ORMP (Oramed Pharmaceuticals) average time for price targets to be met?

On average it took 125.75 days on average for the stock forecasts to be realized with a an average price target met ratio 55

Which analyst has the current highest performing score on ORMP (Oramed Pharmaceuticals) with a proven track record?

RAGHURAM SELVARAJU

Which analyst has the current lower performing score on ORMP (Oramed Pharmaceuticals) with a proven track record?

JIM MOLLOY

Which analyst has the most public recommendations on ORMP (Oramed Pharmaceuticals)?

Raghuram Selvaraju has 3 price targets and 16 ratings on ORMP

Which analyst is the currently most bullish on ORMP (Oramed Pharmaceuticals)?

Jim Molloy with highest potential upside - $37.78

Which analyst is the currently most reserved on ORMP (Oramed Pharmaceuticals)?

Edward Nash with lowest potential downside - -$0.82

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?